LINACS

Drug Index Methods Publications News About

Home › Targeted Therapy › JAK-STAT inhibitors

Drug Class

JAK-STAT inhibitors

Ruxolitinib

LINACS · Living systematic review on the safety of SBRT combined with systemic therapies
EORTC-ESTRO · OligoCare · PROSPERO CRD42024559453